ICD 10 Range Certain disorders involving the immune mechanism

• 1 Immunodeficiency with predominantly antibody defects( D80 )

• 2 Hereditary hypogammaglobulinemia( D80.0 )

• 3 Nonfamilial hypogammaglobulinemia( D80.1 )

• 4 Selective deficiency of immunoglobulin A [IgA]( D80.2 )

• 5 Selective deficiency of immunoglobulin G [IgG] subclasses( D80.3 )

• 6 Selective deficiency of immunoglobulin M [IgM]( D80.4 )

• 7 Immunodeficiency with increased immunoglobulin M [IgM]( D80.5 )

• 8 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia( D80.6 )

• 9 Transient hypogammaglobulinemia of infancy( D80.7 )

• 10 Other immunodeficiencies with predominantly antibody defects( D80.8 )

• 11 Immunodeficiency with predominantly antibody defects, unspecified( D80.9 )

• 12 Combined immunodeficiencies( D81 )

• 13 Severe combined immunodeficiency [SCID] with reticular dysgenesis( D81.0 )

• 14 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers( D81.1 )

• 15 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers( D81.2 )

• 16 Adenosine deaminase [ADA] deficiency( D81.3 )

• 17 Adenosine deaminase deficiency, unspecified( D81.30 )

• 18 Severe combined immunodeficiency due to adenosine deaminase deficiency( D81.31 )

• 19 Adenosine deaminase 2 deficiency( D81.32 )

• 20 Other adenosine deaminase deficiency( D81.39 )

• 21 Nezelof's syndrome( D81.4 )

• 22 Purine nucleoside phosphorylase [PNP] deficiency( D81.5 )

• 23 Major histocompatibility complex class I deficiency( D81.6 )

• 24 Major histocompatibility complex class II deficiency( D81.7 )

• 25 Other combined immunodeficiencies( D81.8 )

• 26 Biotin-dependent carboxylase deficiency( D81.81 )

• 27 Biotinidase deficiency( D81.810 )

• 28 Other biotin-dependent carboxylase deficiency( D81.818 )

• 29 Biotin-dependent carboxylase deficiency, unspecified( D81.819 )

• 30 Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]( D81.82 )

• 31 Other combined immunodeficiencies( D81.89 )

• 32 Combined immunodeficiency, unspecified( D81.9 )

• 33 Immunodeficiency associated with other major defects( D82 )

• 34 Wiskott-Aldrich syndrome( D82.0 )

• 35 Di George's syndrome( D82.1 )

• 36 Immunodeficiency with short-limbed stature( D82.2 )

• 37 Immunodeficiency following hereditary defective response to Epstein-Barr virus( D82.3 )

• 38 Hyperimmunoglobulin E [IgE] syndrome( D82.4 )

• 39 Immunodeficiency associated with other specified major defects( D82.8 )

• 40 Immunodeficiency associated with major defect, unspecified( D82.9 )

• 41 Common variable immunodeficiency( D83 )

• 42 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function( D83.0 )

• 43 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders( D83.1 )

• 44 Common variable immunodeficiency with autoantibodies to B- or T-cells( D83.2 )

• 45 Other common variable immunodeficiencies( D83.8 )

• 46 Common variable immunodeficiency, unspecified( D83.9 )

• 47 Other immunodeficiencies( D84 )

• 48 Lymphocyte function antigen-1 [LFA-1] defect( D84.0 )

• 49 Defects in the complement system( D84.1 )

• 50 Other specified immunodeficiencies( D84.8 )

• 51 Immunodeficiency due to conditions classified elsewhere( D84.81 )

• 52 Immunodeficiency due to drugs and external causes( D84.82 )

• 53 Immunodeficiency due to drugs( D84.821 )

• 54 Immunodeficiency due to external causes( D84.822 )

• 55 Other immunodeficiencies( D84.89 )

• 56 Immunodeficiency, unspecified( D84.9 )

• 57 Sarcoidosis( D86 )

• 58 Sarcoidosis of lung( D86.0 )

• 59 Sarcoidosis of lymph nodes( D86.1 )

• 60 Sarcoidosis of lung with sarcoidosis of lymph nodes( D86.2 )

• 61 Sarcoidosis of skin( D86.3 )

• 62 Sarcoidosis of other sites( D86.8 )

• 63 Sarcoid meningitis( D86.81 )

• 64 Multiple cranial nerve palsies in sarcoidosis( D86.82 )

• 65 Sarcoid iridocyclitis( D86.83 )

• 66 Sarcoid pyelonephritis( D86.84 )

• 67 Sarcoid myocarditis( D86.85 )

• 68 Sarcoid arthropathy( D86.86 )

• 69 Sarcoid myositis( D86.87 )

• 70 Sarcoidosis of other sites( D86.89 )

• 71 Sarcoidosis, unspecified( D86.9 )

• 72 Other disorders involving the immune mechanism, not elsewhere classified( D89 )

• 73 Polyclonal hypergammaglobulinemia( D89.0 )

• 74 Cryoglobulinemia( D89.1 )

• 75 Hypergammaglobulinemia, unspecified( D89.2 )

• 76 Immune reconstitution syndrome( D89.3 )

• 77 Mast cell activation syndrome and related disorders( D89.4 )

• 78 Mast cell activation, unspecified( D89.40 )

• 79 Monoclonal mast cell activation syndrome( D89.41 )

• 80 Idiopathic mast cell activation syndrome( D89.42 )

• 81 Secondary mast cell activation( D89.43 )

• 82 Hereditary alpha tryptasemia( D89.44 )

• 83 Other mast cell activation disorder( D89.49 )

• 84 Other specified disorders involving the immune mechanism, not elsewhere classified( D89.8 )

• 85 Graft-versus-host disease( D89.81 )

• 86 Acute graft-versus-host disease( D89.810 )

• 87 Chronic graft-versus-host disease( D89.811 )

• 88 Acute on chronic graft-versus-host disease( D89.812 )

• 89 Graft-versus-host disease, unspecified( D89.813 )

• 90 Autoimmune lymphoproliferative syndrome [ALPS]( D89.82 )

• 91 Cytokine release syndrome( D89.83 )

• 92 Cytokine release syndrome, grade 1( D89.831 )

• 93 Cytokine release syndrome, grade 2( D89.832 )

• 94 Cytokine release syndrome, grade 3( D89.833 )

• 95 Cytokine release syndrome, grade 4( D89.834 )

• 96 Cytokine release syndrome, grade 5( D89.835 )

• 97 Cytokine release syndrome, grade unspecified( D89.839 )

• 98 IgG4-related disease( D89.84 )

• 99 Other specified disorders involving the immune mechanism, not elsewhere classified( D89.89 )

• 100 Disorder involving the immune mechanism, unspecified( D89.9 )